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Abstract
Background: Although previous studies have suggested that lavender oil promote wound healing, no study has
examined the molecular mechanisms of its effect. In this study, we investigated the effect of lavender oil on various
steps of wound healing and its molecular mechanism, focusing on transforming growth factor-β (TGF-β).
Methods: Circular full-thickness skin wounds were produced on rats. Control solution or lavender oil was topically
applied to the wounds on alternating days for 14 days.
Results: The area of wounds topically treated with lavender oil was significantly decreased as compared to
that of wounds of control rats at 4, 6, 8, and 10 days after wounding. Topical application of lavender oil
induced expression of type I and III collagen at 4 days after wounding, accompanied by an increased number
of fibroblasts, which synthesize collagen. Induced expression of type III collagen by topical application of lavender oil
was reduced to control level at 7 days after wounding although increased expression of type I collagen still continued
even at 7 days, suggesting rapid collagen replacement from type III to type I in wounds treated with lavender oil.
Importantly, expression of TGF-β in wounds treated with lavender oil was significantly increased as compared to
control. Moreover, an increased number of myofibroblasts was observed in wounds treated with lavender oil at
4 days after wounding, suggesting promotion of differentiation of fibroblasts through induction of TGF-β, which is
needed for wound contraction.
Conclusion: This study demonstrated that topical application of lavender oil promoted collagen synthesis and
differentiation of fibroblasts, accompanied by up-regulation of TGF-β. These data suggest that lavender oil has
the potential to promote wound healing in the early phase by acceleration of formation of granulation tissue,
tissue remodeling by collagen replacement and wound contraction through up-regulation of TGF-β. The beneficial
effect of lavender oil on wound healing may raise the possibility of new approaches as complementary treatment
besides conventional therapy.
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Background
The use of complementary and alternative medicines
(CAMs) to treat a variety of conditions is increasing,
and interest in their potential has been growing all over
the world. Aromatherapy, which employs essential oils
extracted from various plants and herbs, is widely used
and is becoming a major CAM. Among various CAMs,
inhalation aromatherapy has especially received atten-
tion mainly for its effects of relaxation and improvement
of emotional or psychological conditions, and some clin-
ical trials have suggested the potential of aromatherapy
for anxiety [1], insomnia [2], stress [3], and pain [4].
Regarding anxiety, efficacy on the clinical outcome is
partially supported by a few studies demonstrating an
anti-conflict effect of essential oils [5, 6] and a metabolic
response to inhalation of essential oils in anxiety model
rats [7]. However, despite the reported beneficial effect
in such clinical trials, these effects are still controversial
because of lack of adequate basic experiments, the small
number of recruited subjects, and lack of rigorous ana-
lytical methods. Further studies, especially basic studies
to elucidate the detail mechanisms of the effects of
essential oils, are needed.
In such situations, the researchers’ interest in the bio-
logical and physiological activities of essential oils has
been increased. In in vitro and in vivo experiments,
some essential oils were suggested to act as anti-
inflammatory [8], anti-viral [9], anti-tumor [10], anti-
hyperglycemic [11], and anti-carcinogenic [12] agents. In
response to these results, targets of aromatherapy and
its therapeutic potentials have expanded from emotional
and psychological symptoms to various physical diseases.
Moreover, these reports unexpectedly suggest that
aromatherapy could be effective through not only inhal-
ation, but also topical application of essential oils, and
the medical indications of aromatherapy have expanded.
Wound healing is one of the expected targets of topical
application of essential oils. This has arisen because a
more efficient strategy is still required in cases of unsuc-
cessful or deficient repair. Useful CAMs that offer an
easy approach, less toxicity and fewer side-effects in
combination with conventional therapy are anticipated
for severe ischemic ulcers or bedsores that are intract-
able due to insufficient growth of granulation tissue and
lack of blood supply. It is already reported that some
essential oils promote wound healing [13–17].
Lavender essential oil is expected to have a benefi-
cial effect on wound healing because a few evidences
for its effect were already reported [16–21]. A previ-
ous randomized control trial conducted on 120
women demonstrated that treatment with lavender oil
significantly reduced pain after episiotomy and red-
ness of incision sites as compared to control [18].
More recently, another randomized clinical trial for
episiotomy demonstrated the similar results; signifi-
cant reduction of REEDA (redness, edema, ecchym-
osis, discharge and approximation) score and visual
analogue scale score for pain, as compared to control
[19]. Both clinical trials suggest beneficial effect of
lavender oil on wound healing. Also, it was reported
that topical treatment with lavender oil on aphthous ulcer-
ation showed a significant ulcer size reduction as com-
pared to control in both an animal experiment and a
clinical study [20]. Moreover, there is a report evaluating
the mechanism of effect of lavender oil on cutaneous
wound healing in an animal experiment [21]. This paper
demonstrated that wound closure progressed more rapidly
with topical application of lavender oil as compared to the
control, accompanied by increased expression of PDGF-A
and EGF, which are growth factors playing important roles
in wound healing process such as tissue remodeling and
re-epithelialization [21].
These clinical trials and animal experiments strongly
suggest wound healing potential of lavender oil. How-
ever, elucidation of the mechanisms, especially the mo-
lecular mechanism, is not enough, and it is still unclear
how essential oils act on various parts of the wound
healing process. Thus, in this study we investigated ef-
fect of lavender oil on wound healing and its molecular
mechanism, using a cutaneous wound animal model. As
wound healing process consists of sequential events such
as formation of granulation tissue, collagen replacement
from type III to type I and wound contraction (wound
shrinking), we evaluated the influence of lavender oil on
each part of wound healing in this study. Moreover,
expression of transforming growth factor-β (TGF-β)
was evaluated as a key molecule playing a role in
healing of wounds topically treated with lavender oil,
because TGF-β is known to regulate proliferation of
fibroblasts, collagen synthesis in fibroblasts, produc-
tion of wound granulation tissue [22], and differenti-
ation of fibroblasts to myofibroblasts in granulation
tissue [23]. Here, we demonstrated the wound healing
potential of lavender oil through induction of TGF-β
in an animal model.
Methods
Procedure of animal experiment
Male Sprague-Dawley rats obtained from Japan SLC
(Shizuoka, Japan), weighing about 250–270 g, were used
in this study. The rats were maintained under constant
room temperature (20–25 °C) with free access to water
and a standard diet throughout the study.
The rats were anesthetized with 1.5 % halothane using
an induction chamber and intraperitoneal administration
of pentobarbital (0.5 ml/kg). After shaving the hair on
their back and cleaning with 70 % ethanol, a circular
full-thickness skin wound (10 mm in diameter) was
Mori et al. BMC Complementary and Alternative Medicine  (2016) 16:144 Page 2 of 11
made in the midline of the back of each animal. Laven-
der oil (Lavandula angustifolia 0.8896 g/ml density) was
dissolved up to 1 % in solution containing 0.1 % DMSO
and Tween 20 because of its lipophilicity. Rats were ran-
domly divided into three groups: (1) Untreated group;
wound surgery only, (2) Control group; wound topically
treated with control solution containing 0.1 % DMSO
and Tween 20, and (3) Lavender group; wound topically
treated with 1 % lavender oil dissolved in control solu-
tion. Then, 50 μl of each solution was applied to the
wound area just after wound surgery, and each treat-
ment was continued on alternating days till 14 days after
surgery. As application of diluted essential oils to the
skin or a wound is a popular approach in humans [24],
diluted lavender essential oil (1 % solution) was applied
to wounds without any ointment base or oleaginous
base, in order to avoid the additional effect of these
bases on the wound healing process. Each rat was
separated to prevent licking the solution and to avoid
serious infection of the wound. The wound area was
digitally photographed at 0, 2, 4, 6, 8, 10, 12 and
14 days after wound surgery using a digital camera
(Canon Power Shot S200, Tokyo, Japan), then the
area was quantified using an image analysis system,
Image J (NIH). Measurements were performed in a
blind manner. Each investigator was blinded to group
assignment and other data concerning the animals, as
well as to the results of the other investigator. Rats
were sacrificed by intraperitoneal administration of an
overdose of pentobarbitonein, to isolate tissue samples
from skin for investigations.
Chemicals and reagents
Lavender oil was purchased from Pranarom, Int.
(Ghislenghien, Belgium). Details about the chemical
composition of lavender oil are shown in Table 1.
The lavender oil we used was extracted by the hydro-
distillation method from Lavandula angstiforia ssp.
angstiforia. It was a pure essential oil, and no other
substances including ointment base were added to the
distilled extract, in order to exclude the effect of
other components. Tween 20 and DMSO were pur-
chased from Wako Pure Chemical Industries (Osaka,
Japan) and Sigma-Aldrich Co. (St Louis, MO, USA),
respectively. All other chemicals were analytical grade.
Immunohistochemical studies
Rats were sacrificed at 4 days after wounding, and skin
tissue was isolated from the wound lesion for histo-
logical examination. Skin tissues were fixed in 10 %
formalin for 24 h and processed for routine paraffin
embedding.
For immunohistochemical staining, anti-type III colla-
gen (Col III) antibody, antibody to α-smooth muscle
actin (α-SMA) (Abcam, Cambridge, MA, USA) and
monoclonal antibody to prolyl-4-hydroxylase (P4H)
(Acris Antibodies, Inc., CA, USA) were used to analyze
the expression of type III collagen and collagen synthesis
in fibroblasts, respectively, in wound lesions of the rat
model. Also, antibody to α-SMA was used to detect
myofibroblasts. Immunohistochemical staining was per-
formed using the high polymer, HISTOFINE simple
stain rat MAX-PO (Nichirei Bioscience Inc., Tokyo,
Japan) method. Then, 5-μm sections were deparaffinized,
rehydrated before blocking endogenous peroxidase ac-
tivity with 3 % hydrogen peroxide, and pre-incubated
with 1.5 % blocking reagent (Roche Applied Science,
Indianapolis, USA) in Tris-HC1 buffered saline (TBS)
for 1 h. Diluted primary antibodies (Col III 1:600,
P4H 1:20, α-SMA 1:100) were then applied to the
sections, and these sections were incubated for 1 h.
Following this, the specimens were rinsed twice with
TBS for 5 min and incubated with HISTOFINE sim-
ple stain rat MAX-PO (mouse) (Nichirei Bioscience
Inc.) for 30 min. Peroxidase activity was visualized by
treatment with 0.05 % diaminobenzidine containing
0.3 % hydrogen peroxide. After the samples were
rinsed in water, the sections were dehydrated, cleared
and mounted.
Expression of mRNA of type I collagen and type III
collagen
Rats were sacrificed at 4 and 7 days after wounding, and
skin tissue was isolated from wound lesions. Excised tis-
sues were homogenized in cold PBS and centrifuged at
20,000 g for 15 min at 4 °C. Total RNA of tissue samples
Table 1 Details about the chemical composition of lavender oil
Constituent % Constituent %
Monoterpene alcohols 47.52 % Monoterpene hydrocarbons 5.09 %
linalool 43.00 % trans-β-ocimene 1.92 %
borneol 1.80 % cis-β-ocimene 1.47 %
α- terpineol 1.02 % camphene 0.28 %
terpinen-4-ol 0.91 % limonene 0.25 %
geraniol 0.59 % others
others
Esters 34.81 % Sesquiterpene hydrocarbons 4.58 %
linalyl acetate 32.09 % β-caryophyllene 2.80 %
lavandulyl acetate 1.29 % β-farnesene 1.46 %
1-octen-3-yl acetate 0.59 % germacrene D 0.15 %
hexyl acetate 0.40 % others
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was extracted using ISOGEN II (NIPPON GENE, To-
yama, Japan) and re-suspended in PBS, and purity was
assessed by spectrophotometry. Only samples with a ra-
tio of spectrophotometric absorbance at 260 nm to that
at 280 nm (A260/A280) in the range of 1.9–2.1 were
used. Complementary DNA was synthesized using an
iScript cDNA Synthesis Kit (Bio-Rad Laboratories,
Hercules, CA, USA). Amplification reactions were per-
formed with SsoFast EvaGreen Supermix (Bio-Rad) with
1 μm of primers and 4 μl of cDNA in a final volume of
50 μl, and were carried out in a MiniOpticon Real-Time
PCR Detection System (Bio-Rad), according to the
manufacturer’s instructions (1 min at 95 °C followed
by 40 cycles of 1 s at 95 °C and 5 s at 60 °C). The
expression level of GAPDH as a housekeeping gene
was used as the internal control, and the comparative
Ct method (2ΔΔCt) was used to quantify gene expres-
sion levels. The values are shown as relative expres-
sion by delta Ct (subtraction of the crossing point
cycle for the housekeeping gene from that of the gene
analyzed). The oligonucleotides were synthesized by
Gene Design (Suita, Japan). Sequences of primers are
shown in Table 2 [25–27].
Enzyme-linked immunosorbent assay for TGF-β
Rats were sacrificed at 4 and 7 days after wounding, and
skin tissue was isolated from wound lesions to extract
proteins in each group. Tissues were homogenized, and
extraction of proteins was performed using T-PER
Tissue Protein Extraction Reagent (Pierce, Rockford,
IL, USA) according to the manufacturer’s instructions.
Protein concentrations were determined using Bio-
Rad Protein Assay (Bio-Rad, Hercules, CA) reagent
with bovine serum albumin as standard. Protein levels
of TGF-β in skin tissue were measured using an
enzyme-linked immunosorbent assay (ELISA) kit ac-
cording to the manufacturer’s instructions (RayBiotech
Inc., Norcross, GA, USA).
Statistical analysis
All numerical values are expressed as mean ± SEM. Data
sets were analyzed by unpaired Student’s t-test or ana-
lysis of variance (ANOVA) followed by Tukey-Kramer
post hoc test. Differences with p <0.05 were considered
statistically significant.
Results
Effect of lavender oil on wound healing
Representative photographs of the process of wound
healing in each group are shown in Fig. 1. The photo-
graphs suggest that topical application of lavender oil
promotes wound closure, with a reduction in wound
area. To perform accurate and quantitative analysis, the
area of wound lesions in each group was measured using
Image J at 0, 2, 4, 6, 8, 10, 12, and 14 days after wound-
ing (Fig. 2). There was no significant difference in the
wound area between untreated and control rats at each
time point. However, wound closure was observed to
progress more rapidly with topical application of laven-
der oil. The wound area of rats treated with lavender oil
was significantly decreased as compared to that of un-
treated rats and control rats at 4, 6, 8, and 10 days after
wounding (at day 4, 6, 8: p <0.01 vs untreated and con-
trol; at day 10: p <0.05 vs untreated and control) (Fig. 2).
There was no significant difference in wound size at 12
and 14 days (Fig. 2). These data suggest wound healing
potential of lavender oil in the early phase. Serious infec-
tion was not observed in each animal of each group, and
it was considered that there was little effect of infection
on wound healing in our experiment.
Proliferation of fibroblasts and synthesis of collagen
Immunohistochemical studies demonstrated an in-
creased number of P4H-positive cells, indicating fibro-
blasts that synthesize collagen, in wound lesions
topically treated with lavender oil as compared to that in
wound lesions treated with control solution (Fig. 3a, b).
Then, we assessed collagen secretion by fibroblasts. As
shown in Fig. 3c and d, immunochemical staining
showed that production of type III collagen (Col III),
which is essential for formation of granulation tissue in
the early phase of wound healing, was increased by top-
ical treatment with lavender oil, accompanied by an
increased number of P4H-positive fibroblasts (Fig. 3b).
Also, expression of each collagen was confirmed by RT-
PCR. At 4 days after wounding, expression of mRNA of
both type III collagen (Col IIIa1) and type I collagen (Col
Ia2) in skin tissues of wound lesions topically treated with
lavender oil was significantly increased as compared to
that of those treated with control solution (p <0.01 vs con-
trol) (Fig. 4a, b), suggesting acceleration of formation of
granulation tissue in the early phase of wound healing.
Moreover, expression of Col IIIa1 in wound lesions
Table 2 Primers designed for real-time PCR
Name Sense primer (5′-3′) Antisense primer (5′-3′)
rat type I collagen a2 GCTTTGTGGATACGCGAACTC CCAGCATTGGCATGTTGCT
rat type III collagen a1 TGATGGGATCCAATGAGGGAG GAGTCTCATGGCCTTGCGTGTTT
rat GAPDH ATGGCACAGTCAAGGCTGAGA CGCTCCTG GAAGATGGTGAT
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topically treated with lavender oil rapidly decreased to the
control level by 7 days after wounding (Fig. 4c), while sig-
nificantly higher expression of Col Ia2 by treatment with
lavender oil as compared to control was still observed even
at 7 days after wounding (Fig. 4d). This suggests that treat-
ment with lavender oil results in promotion of tissue re-
modeling by rapid replacement of type III collagen with
type I collagen. There was no significant difference in ex-
pression of Col Ia2 and Col IIIa1 between the untreated
group and control group (4 days; Col Ia2/GAPDH of un-
treated: 0.93 ± 0.19, Col IIIa1/GAPDH of untreated: 1.04 ±
0.16, ns vs that of Control, respectively) (7 days; Col Ia2/
GAPDH of untreated: 0.93 ± 0.19, Col IIIa1/GAPDH of
untreated: 1.08 ± 0.08, ns vs that of Control, respectively).
Expression of TGF-β and differentiation of fibroblasts to
myofibroblasts
To investigate the detailed molecular mechanism of the
effect of lavender oil on wound healing, we focused on
expression of TGF-β, as it is already known to induce
proliferation of fibroblasts and synthesis of both type
I and type III collagen [22]. Interestingly, as shown in
Fig. 5, our ELISA study demonstrated that the protein
level of TGF-β in wound lesions topically treated with
lavender oil was significantly increased as compared
to that in those treated with control solution, at both
4 and 7 days after wounding (at day 4, p <0.05 vs
control, at day 7: p <0.01 vs control). There was no
significant difference in expression of TGF-β between
Untreated





Fig. 1 Representative photographs of transition of wound closure in rat model. Untreated; wound surgery only, Control; wound topically treated with
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%
Fig. 2 Transition of wound area measured by Image J. Untreated (▲); rats with surgery only, Control (■); rats treated with control solution
containing 0.1 % DMSO and Tween 20, Lavender (◆); rats treated with 1 % lavender oil dissolved in control solution. Values are mean ± SEM.
n = 6 in each group. **: P <0.01 vs untreated, *: P <0.05 vs untreated, ##: P <0.01 vs Sham, #: P <0.05 vs Sham
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the untreated group and control group (4 days; untreated:
134.73 ± 3.94 pg/ml, Control: 136.44 ± 12.91 pg/ml, ns.
7 days; untreated: 134.17 ± 1.9 pg/ml, Control: 130.97 ±
4.89 pg/ml, ns).
In addition, TGF-β was reported to promote differ-
entiation of fibroblasts into myofibroblasts in wound
granulation tissue [23]. Differentiation to myofibro-
blasts in wound lesions is essential for wound
contraction. Consistent with the previous report, an
increased number of myofibroblasts positively stained
for α-SMA (open arrow heads) was observed in
wound lesions topically treated with lavender oil at
4 days after wounding, in the early phase of the
wound healing process (Fig. 6). This suggests that
treatment with lavender oil accelerates wound con-
traction by myofibroblasts.
Discussion
Wound healing is a natural physiological process that
develops in response to tissue damage, to restore the
function and integrity of damaged skin tissues. The
wound healing process is divided into four overlapping
phases; blood clotting, inflammation, new tissue forma-
tion, and tissue remodeling [28]. These processes, espe-
cially new tissue formation and tissue remodeling,
consist of sequential and coordinated events including
angiogenesis, cellular proliferation, collagen synthesis
followed by formation of granulation tissue, matrix
degradation followed by replacement of collagen, wound
contraction, and scar formation [29–32]. These healing
processes are regulated by a large number of growth
factors, cytokines, mitogens and chemotactic factors.
Among them, epidermal growth factors (EGFs), insulin-
like growth factors (IGFs), platelet-derived growth factors
(PDGFs), and fibroblast growth factors (FGFs) are con-
sidered to play an important role in wound healing
because these growth factors regulate cell migration and
proliferation and the synthesis of extracellular matrix
proteins, which are essential for formation of granulation
tissue [22, 33, 34]. Indeed, there have been several
studies of the transfer into wounds of some of these
genes to promote wound healing and accelerate
wound repair [35–37]. Besides these growth factors,
there has been a focus on TGF-β in the wound heal-
ing process as it is considered to have the broadest
spectrum of effects [22, 38, 39].
Lavender oil is extracted from Lavandula angstiforia
ssp. angstiforia and is popularly used as a CAM in vari-
ous fields of health promotion. There are many reports
suggesting beneficial effects of inhalation of lavender oil
on pain [40], allergic airway inflammation of asthma
[41], anxiety disorder [42], quality of sleep [2, 43], and
dementia [44]. Besides these expected effects, the influ-
ence of topical application of lavender oil on wound
healing has already been evaluated [16–21]. Although








Fig. 3 Representative photomicrographs of immunohistochemical studies. a, b Immunohistochemical staining for P4H at 4 days after wounding.
c, d Immunohistochemical staining for type III collagen at 4 days after wounding. Magnification; × 100. Control; wound topically treated with
control solution containing 0.1 % DMSO and Tween 20, Lavender; wound topically treated with 1 % lavender oil dissolved in control solution
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oil on wound healing, the detailed mechanisms of the
effect have not been fully elucidated. However, there is
an interesting paper demonstrating that wound closure
progressed more rapidly with topical application of
lavender oil as compared to the control, and that expres-
sion of PDGF-A and EGF tended to increase, although
there was no significant difference as compared to the
control [21]. As PDGF-A is known to induce the
secretion of matrix metalloproteinases (MMPs) from
fibroblasts, this study suggests that lavender oil may
accelerate wound closure through a rapid decrease in
granulation tissue induced by PDGF and progression
of re-epithelialization induced by EGF. To our know-
ledge, this was the only study to refer and suggest



















Fig. 5 Expression of TGF-β protein determined by ELISA. a Expression of TGF-β protein at 4 days after wounding. b Expression of TGF-β protein
at 7 days after wounding. Control; wound topically treated with control solution containing 0.1 % DMSO and Tween 20, Lavender; wound topically












































































































At 4 days At 4 days
At 7 days At 7 days
Fig. 4 Expression of mRNA of type I collagen and type III collagen. a Relative mRNA expression of type III collagen (Col IIIa1) at 4 days after
wounding. b Relative mRNA expression of type I collagen (Col Ia2) at 4 days after wounding. c Relative mRNA expression of type III collagen
(Col IIIa1) at 7 days after wounding. d Relative mRNA expression of type I collagen (Col Ia2) at 7 days after wounding. Control; wound topically
treated with control solution containing 0.1 % DMSO and Tween 20, Lavender; wound topically treated with 1 % lavender oil dissolved in control
solution. Values are mean ± SEM. n = 6 in each group. *: p <0.05 vs Control, **: p <0.01 vs Control
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In contrast, in the present study, we demonstrated that
acceleration of the formation of granulation tissue in the
early phase, rather than a rapid decrease in granulation
as previously reported [21], leads to rapid remodeling by
collagen replacement and promotes wound closure. The
current study showed that topical treatment with laven-
der oil increased the number of fibroblasts positively
stained for P4H, which catalyzes proline hydroxylation
of procollagen and is essential for collagen maturation
and synthesis in fibroblasts [45, 46], and induced expres-
sion of both type I and III collagen in wound lesions.
The obtained data suggest that topical treatment with
lavender oil accelerates formation of granulation tissue
in the early phase of wound healing. Moreover, topical
application of lavender oil to wounds is suggested to ad-
vance collagen replacement from type III to type I, based
on our findings that increased expression of type I colla-
gen was observed even at 7 days, although expression of
type III collagen rapidly decreased to the control level by
7 days. As formation of granulation tissue consisting of
collagen and replacement of type III collagen with type I
collagen are essential for tissue remodeling in the wound
healing process, acceleration of formation of granulation
and collagen replacement in the early phase is consid-
ered to promote wound healing. In fact, the wound area
of rats treated with lavender oil was significantly
decreased as compared to that of untreated rats and
control rats at 4, 6, 8, and 10 days after wounding.
A novel finding of the current study is the induction of
expression of TGF-β by treatment with lavender oil.
There has been no report of a complication of TGF-β in-
duction in the wound healing activity of essential oils. It
has been reported that TGF-β stimulates angiogenesis,
proliferation of fibroblasts, and matrix production by
fibroblasts [22, 47, 48], and that it could be one of key
molecules in the wound healing process [32, 37, 38, 49].
From these previous reports, TGF-β is considered to play
a prominent role in cutaneous wound healing by
acceleration of formation of granulation tissue, accom-
panied by increased production of collagen by fibroblasts.
Thus, the up-regulation of TGF-β by treatment with
lavender oil observed in the present study can rationally
explain the proliferation of fibroblasts which synthesize
collagen and increased mRNA expression of collagen.
TGF-β and collagen are considered to be expressed in a
coordinated manner to form granulation in the wound.
Also, TGF-β was reported to induce secretion of MMP-
13, so-called collagenase-3, by fibroblasts [50]. MMP-13
is essential for degradation of type III collagen, followed
by replacement by type I collagen and tissue remodeling
in the process of wound healing. In the present study,
despite a significant increase in type III collagen at 4 days
after the start of topical treatment with lavender oil, it
rapidly decreased to the control level by 7 days. Rapid
degradation of type III collagen is strongly suggested to
be mediated by MMP-13, which is induced by up-
regulation of TGF-β. Taken together, these findings indi-
cate that induction of TGF-β by lavender oil functions to
accelerate not only the formation of granulation tissue







Fig. 6 Representative photomicrographs of immunohistochemical studies. a, b Wound lesion stained by hematoxylin-eosin staining at 4 days
after wounding. Magnification; × 40. c, d Immunohistochemical staining for α-SMA at 4 days after wounding. Magnification; × 200. Control;
wound topically treated with control solution containing 0.1 % DMSO and Tween 20, Lavender; wound topically treated with 1 % lavender oil
dissolved in control solution. Gr granulation, Nt normal tissue. Closed arrow heads indicate representative myofibroblasts and open arrow heads
indicate representative vascular smooth muscle cells around vasculature
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Another important finding of the present study is that
topical treatment with lavender oil promoted differenti-
ation of fibroblasts to myofibroblasts in wound granula-
tion in the early phase of wound healing. This can also
be explained by up-regulation of TGF-β, because TGF-β
has been reported to stimulate differentiation of fibro-
blasts to myofibroblasts [23], which play a major role in
tissue shrinking/contraction in the wound healing
process. Also, it was reported that stimulation of the
TGF-β signaling pathway by angiotensin II induces
granulation tissue contraction via the angiotensin type 1
receptor [51]. Thus, the present data also showed that
induction of TGF-β by topical application of lavender oil
promotes not only formation of granulation tissue, but
also wound shrinking/contraction. Moreover, a previous
study demonstrated that suppression of type III collagen
in the wound area enhanced myofibroblast expression
[52], and that diminished type III collagen promotes
myofibroblast differentiation [49]. From this point of
view, lavender oil may promote wound shrinking/con-
traction, because our data demonstrated that rapid deg-
radation of type III collagen was observed in wounds
topically treated with lavender oil.
There are some issues and study limitations of our
study. First, it is unclear whether essential oils induce
inflammation or not. The up-regulation of TGF-β ob-
served in our study suggests that inflammation is in-
duced in wound lesions topically treated with lavender
oil, because inflammation is a major factor that induces
the expression of TGF-β. Considering that inflammation
is essential for progression of wound healing, our find-
ings are rational. However, lavender is generally reported
to be an effective medicinal plant for treating inflamma-
tion. Indeed, some papers suggest an anti-inflammatory
effect of lavender oil [41, 53]. On the other hand, there
is a report showing that other essential oils induce a cu-
taneous inflammatory response in wound lesions [54].
No conclusion has been reached because of insufficient
basic studies. Further study is needed to resolve this
question and to prove the rationality of the data ob-
tained from this study. The second issue is that in the
present study there was no difference in the total num-
ber of days (14 days) needed for complete healing,
although the area of wounds topically treated with laven-
der oil was significantly decreased at 4, 6, 8, and 10 days
after wounding. Our data indicate that lavender oil ac-
celerates wound healing only in the early phase. This
may be explained by lavender oil-induced promotion of
formation of granulation tissue, replacement of collagen
and wound contraction, which mainly occur in the early
phase of wound healing. Especially, the decreased wound
size after 4 to 10 days of treatment with lavender oil
may be consequent upon wound contraction. On the
other hand, considering the lack of difference in total
days needed for complete healing, lavender oil may have
no influence on re-epithelialization for wound closure.
This is the opposite result to that of a previous study that
suggested acceleration of re-epithelialization through in-
duction of EGF by topical application of lavender oil [21].
Detailed investigation of the effect of lavender oil on
expression of other growth factors and its influence on
other steps of wound healing are awaited. Finally, it is still
unclear which component of lavender oil (Table 1) has the
observed effect in this study. Although linalool and linalyl
acetate, which are the major components of lavender oil
(Table 1), are reported to have an anti-microbial [55] and
an anti-inflammatory effect [56], the participation of these
components in the proposed mechanism of lavender oil
was not evaluated in this study. As the aim of this study
was to evaluate the effect of whole lavender oil which is
popularly and practically used in humans, component
analysis of the lavender oil we used and investigation of
the effect of each constituent should be studied in further
experiments.
Conclusions
The present study demonstrated that topical treatment
with lavender oil significantly increased collagen synthe-
sis by fibroblasts, accompanied by enhanced expression
of TGF-β in wound lesions. Also, rapid replacement of
type III collagen with type I collagen in wounds treated
with lavender oil was suggested by the finding that in-
creased expression of type III collagen decreased to the
control level by 7 days, while type I collagen was not re-
duced even at 7 days. Moreover, an increased number of
myofibroblasts, probably due to up-regulation of TGF-β,
was observed in the early phase of the wound healing
process in wound lesions topically treated with lavender
oil, suggesting that treatment with lavender oil also ac-
celerates wound contraction by myofibroblasts. Overall,
the present data demonstrated that topical application of
lavender oil to wounds accelerates wound healing
through 1) formation of granulation tissue by collagen
synthesis, 2) tissue remodeling by collagen replacement
from type III to type I, and 3) wound contraction
(wound shrinking). Of importance, this paper firstly sug-
gests that TGF-β is involved in the mechanism of the
effect of lavender oil on wound healing. The beneficial
effect of lavender oil on wound healing may raise the
possibility of new approaches as complementary treat-
ment besides conventional therapy.
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